Nav: Home

Group B streptococcus test for pregnant women: advantage of universal screening unclear

February 05, 2019

Serological group B streptococci (GBS) are common bacteria, which usually remain unnoticed. This is also the case for the almost 20% of pregnant women with vaginal or anal colonization of GBS. The bacteria pose a risk for the babies, however: In the worst case, an infection at birth can cause sepsis or meningitis in the newborn. To prevent these complications, pregnant women with certain risk factors receive antibiotics shortly before birth (risk strategy). However, there is also a test on the market that could be offered to all pregnant women (testing strategy). This test could detect also those pregnant women who have no risk factor, but still carry GBS.

The German Institute for Quality and Efficiency in Health Care (IQWiG) therefore investigated whether universal screening, i.e. the testing strategy, would offer advantages, and hence an added benefit, for newborns or expectant mothers in comparison with the currently used risk strategy. The final report now presented confirms the results of the preliminary report from 2018. According to the findings, this question cannot be answered as there are no informative studies for the comparison. In the Institute's opinion, it is unrealistic that these kinds of studies will be conducted in the future because it is very difficult to achieve the large sample sizes required.

Antibiotics are standard treatment for certain risks

About one in 3000 newborns is infected with GBS at birth; 3.2% of them die of the consequences. Pregnant women receive antibiotic prophylaxis if they have a fever, if there is a risk of premature birth, or if the birthing process is very slow, for example. This risk strategy can already prevent most infections. As an alternative option, all expectant mothers could be offered a microbiological examination in the form of the GBS test (universal screening). However, the test, which costs between 10 and 30 euros, is not a standard treatment reimbursed by German statutory health insurance funds - unless there is a risk of premature birth.

Study results not sufficiently robust

As was the case in the preliminary report, the Institute identified no study that could have provided robust results. There is a large "cohort study" comparing both strategies with each other (Schrag 2002), which is also referred to by the medical society. However, the Institute still rates its results as not sufficiently certain. The main reason is that there were notable differences between the participants not only regarding the test, but also in other characteristics. A lower complication rate, for example, could therefore have many reasons. The study also showed no "dramatic effects", i.e. no very large differences.

Studies on "screening chain" not realistic

In the final report, the Institute also showed scepticism whether it will ever be possible to conduct informative studies on the total so-called screening chain. Such studies would have to include several hundreds of thousands of pregnant women to ensure sufficient certainty of results. The large sample size is required as infections and their complications overall are rare. In smaller sample sizes, differences between the groups, e.g. the frequency of sepsis in newborns, could be due to chance alone.

In contrast, studies investigating which strategy is better at reducing the currently frequent use of antibiotics are considered reasonable and feasible by IQWiG. Quick tests used during labour, which are already approved in the United States, should also be considered as another prevention strategy in these studies.
-end-
Final Report (German version): https://www.iqwig.de/en/projects-results/projects/non-drug-interventions/s-projekte/s17-02-screening-for-serological-group-b-streptococci-within-the-framework-of-the-medical-check-ups-according-to-the-maternity-guidelines.8017.html

Institute for Quality and Efficiency in Health Care

Related Pregnant Women Articles:

Pregnant women could get on their bikes and stay healthy with better support
Medical advice from risk-averse health professionals may contribute to some women's decisions to stop cycling to work during pregnancy, meaning they miss out on the potential benefits of the active commute.
Hepatitis C increasing among pregnant women
Hepatitis C infections among pregnant women nearly doubled from 2009-2014, likely a consequence of the country's increasing opioid epidemic that is disproportionately affecting rural areas of states including Tennessee and West Virginia.
Screening for preeclampsia in pregnant women recommended
The US Preventive Services Task Force (USPSTF) recommends screening for preeclampsia in pregnant women with blood pressure measurements throughout pregnancy.
Signs point to reduced drinking by pregnant women
The signage varies but the message is working. Drinking by pregnant women is down 11 percent in states requiring point-of-sale warning signs, says a health economist at the University of Oregon.
A new study confirms: Pregnant women should avoid liquorice
A new Finnish study supports food recommendations for families with children in that women should avoid consuming large amounts of liquorice during pregnancy.
Pregnant women at risk of getting the flu are not getting vaccinated
Health-care professionals are hesitant to administer the flu vaccine to pregnant women, despite the potential life-saving benefits, according to a UBC study.
Customized vitamin D supplements may benefit pregnant women
Individualized supplement doses help protect pregnant women from vitamin D deficiency, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.
Pregnant women may need more information about medicine use
Pregnant women overestimate the risks of taking over the counter and prescribed medication.
Women with epilepsy just as likely to get pregnant as healthy women of childbearing age
In a prospective study, women with epilepsy had a comparable likelihood of achieving pregnancy, time taken to get pregnant, and pregnancy outcomes such as miscarriage, compared to a group of healthy peers.
New app advises and reminds pregnant women about vaccinations
A new app to guide and remind pregnant women about vaccines recommended during pregnancy has been launched by researchers.

Related Pregnant Women Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Anthropomorphic
Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#532 A Class Conversation
This week we take a look at the sociology of class. What factors create and impact class? How do we try and study it? How does class play out differently in different countries like the US and the UK? How does it impact the political system? We talk with Daniel Laurison, Assistant Professor of Sociology at Swarthmore College and coauthor of the book "The Class Ceiling: Why it Pays to be Privileged", about class and its impacts on people and our systems.